Skip to content. | Skip to navigation

Personal tools



This folder holds the following references to publications, sorted by year and author.

There are 80 references in this bibliography folder.

Vujovic, M, Nordstrom, K, Gauthier, K, Flamant, F, Visser, TJ, Vennstrom, B, and Mittag, J (2009).
Interference of a mutant thyroid hormone receptor alpha1 with hepatic glucose metabolism
Endocrinology, 150(6):2940-7.

Winter, H, Ruttiger, L, Muller, M, Kuhn, S, Brandt, N, Zimmermann, U, Hirt, B, Bress, A, Sausbier, M, Conscience, A, Flamant, F, Tian, Y, Zuo, J, Pfister, M, Ruth, P, Lowenheim, H, Samarut, J, Engel, J, and Knipper, M (2009).
Deafness in TRbeta mutants is caused by malformation of the tectorial membrane
J Neurosci, 29(8):2581-7.

Bassett, JH, Williams, AJ, Murphy, E, Boyde, A, Howell, PG, Swinhoe, R, Archanco, M, Flamant, F, Samarut, J, Costagliola, S, Vassart, G, Weiss, RE, Refetoff, S, and Williams, GR (2008).
A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism
Mol Endocrinol, 22(2):501-12.

Flamant, F and Quignodon, L (2008).
[Thyroid hormone and its receptors: have mouse genetics clarified the situation?]
J Soc Biol, 202(2):67-71.

Crozet, C, Lezmi, S, Flamant, F, Samarut, J, Baron, T, and Bencsik, A (2007).
Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only
J Infect Dis, 195(7):997-1006.

Dkhissi-Benyahya, O, Gronfier, C, De Vanssay, W, Flamant, F, and Cooper, HM (2007).
Modeling the role of mid-wavelength cones in circadian responses to light
Neuron, 53(5):677-87.

Flamant, F, Gauthier, K, and Samarut, J (2007).
Thyroid hormones signaling is getting more complex: STORMs are coming
Mol Endocrinol, 21(2):321-33.

Quignodon, L, Grijota-Martinez, C, Compe, E, Guyot, R, Allioli, N, Laperriere, D, Walker, R, Meltzer, P, Mader, S, Samarut, J, and Flamant, F (2007).
A combined approach identifies a limited number of new thyroid hormone target genes in post-natal mouse cerebellum
J Mol Endocrinol, 39(1):17-28.

Quignodon, L, Vincent, S, Winter, H, Samarut, J, and Flamant, F (2007).
A point mutation in the activation function 2 domain of thyroid hormone receptor alpha1 expressed after CRE-mediated recombination partially recapitulates hypothyroidism
Mol Endocrinol, 21(10):2350-60.

Flamant, F, Baxter, JD, Forrest, D, Refetoff, S, Samuels, H, Scanlan, TS, Vennstrom, B, and Samarut, J (2006).
International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors
Pharmacol Rev, 58(4):705-11.

Bonnafe, E, Touka, M, AitLounis, A, Baas, D, Barras, E, Ucla, C, Moreau, A, Flamant, F, Dubruille, R, Couble, P, Collignon, J, Durand, B, and Reith, W (2004).
The transcription factor RFX3 directs nodal cilium development and left-right asymmetry specification
Mol Cell Biol, 24(10):4417-27.

Dupre, SM, Guissouma, H, Flamant, F, Seugnet, I, Scanlan, TS, Baxter, JD, Samarut, J, Demeneix, BA, and Becker, N (2004).
Both thyroid hormone receptor (TR)beta 1 and TR beta 2 isoforms contribute to the regulation of hypothalamic thyrotropin-releasing hormone
Endocrinology, 145(5):2337-45.

Mai, W, Janier, MF, Allioli, N, Quignodon, L, Chuzel, T, Flamant, F, and Samarut, J (2004).
Thyroid hormone receptor alpha is a molecular switch of cardiac function between fetal and postnatal life
Proc Natl Acad Sci U S A, 101(28):10332-7.

Quignodon, L, Legrand, C, Allioli, N, Guadano-Ferraz, A, Bernal, J, Samarut, J, and Flamant, F (2004).
Thyroid hormone signaling is highly heterogeneous during pre- and postnatal brain development
J Mol Endocrinol, 33(2):467-76.

Flamant, F and Samarut, J (2003).
Thyroid hormone receptors: lessons from knockout and knock-in mutant mice
Trends Endocrinol Metab, 14(2):85-90.

Poguet, AL, Legrand, C, Feng, X, Yen, PM, Meltzer, P, Samarut, J, and Flamant, F (2003).
Microarray analysis of knockout mice identifies cyclin D2 as a possible mediator for the action of thyroid hormone during the postnatal development of the cerebellum
Dev Biol, 254(2):188-99.

Yen, PM, Feng, X, Flamant, F, Chen, Y, Walker, RL, Weiss, RE, Chassande, O, Samarut, J, Refetoff, S, and Meltzer, PS (2003).
Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice
EMBO Rep, 4(6):581-7.

Baas, D, Legrand, C, Samarut, J, and Flamant, F (2002).
Persistence of oligodendrocyte precursor cells and altered myelination in optic nerve associated to retina degeneration in mice devoid of all thyroid hormone receptors
Proc Natl Acad Sci U S A, 99(5):2907-11.

Flamant, F, Poguet, AL, Plateroti, M, Chassande, O, Gauthier, K, Streichenberger, N, Mansouri, A, and Samarut, J (2002).
Congenital hypothyroid Pax8(-/-) mutant mice can be rescued by inactivating the TRalpha gene
Mol Endocrinol, 16(1):24-32.

Gauthier, K, Aubert, D, Chassande, O, Flamant, F, and Samarut, J (2002).
Null mutant mice for thyroid hormone receptors
Methods Mol Biol, 202:13-29.

Crozet, C, Bencsik, A, Flamant, F, Lezmi, S, Samarut, J, and Baron, T (2001).
Florid plaques in ovine PrP transgenic mice infected with an experimental ovine BSE
EMBO Rep, 2(10):952-6.

Crozet, C, Flamant, F, Bencsik, A, Aubert, D, Samarut, J, and Baron, T (2001).
Efficient transmission of two different sheep scrapie isolates in transgenic mice expressing the ovine PrP gene
J Virol, 75(11):5328-34.

Revol, V, Tsuboi, I, Flamant, F, Samarut, J, Blanchet, JP, and Mouchiroud, G (1999).
A novel growth-factor-dependent myeloid cell line derived from mouse bone marrow cells contains progenitors endowed with high proliferative potential
Exp Hematol, 27(1):88-98.

Flamant, F and Samarut, J (1998).
Involvement of thyroid hormone and its alpha receptor in avian neurulation
Dev Biol, 197(1):1-11.

Chassande, O, Fraichard, A, Gauthier, K, Flamant, F, Legrand, C, Savatier, P, Laudet, V, and Samarut, J (1997).
Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities
Mol Endocrinol, 11(9):1278-90.

Document Actions